FindTrial
Sign In

Utility of Interferon Gamma Releasing Assay for diagnosis of active Tuberculosis in children under 18 years old age: a systematic review and meta-analysis

Utility of Interferon Gamma Releasing Assay for diagnosis of active Tuberculosis in children under 18 years old age: a systematic review and meta-analysis - Utility of Interferon Gamma Releasing Assay for diagnosis of active Tuberculosis in children under 18 years old age: a systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000046737
Enrollment
Unknown
Registered
2022-02-01
Start date
2022-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis in children

Interventions

None listed

Sponsors

Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: People who were under 18 years old and received a IGRA test.

Exclusion criteria

Exclusion criteria: Nothing special

Design outcomes

Primary

MeasureTime frame
Accuracy of Interferon Gamma Releasing Assay (IGRA) to detect active tuberculosis in children—

Secondary

MeasureTime frame
1) Accuracy of IGRA among different age groups (aged 0-4, 5-14 years old) 2) Accuracy of IGRA in non-HIV group 3) Accuracy of IGRA using different kits 4) Accuracy of IGRA among pulmonary tuberculosis or extrapulmonary tuberculosis 5) Comparison of accuracy between IGRA and TST—

Countries

Japan

Contacts

Public ContactHirotomo Yamanashi

Nagasaki University Graduate School of Biomedical Sciences Department of General Medicine

yamanashi@nagasaki-u.ac.jp095-819-7591

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026